首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1767706

Crispr 和 Cas 基因市場（按產品類型、應用、最終用戶和地區分類）

Crispr and Cas Gene Market, By Product Type, By Application, By End User, By Geography

出版日期: 2025年06月02日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年 Crispr 和 Cas 基因市場規模為 23.2 億美元，到 2032 年將達到 97.7 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 22.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	23.2億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年	22.80%	2032年價值預測	97.7億美元

成簇規律間隔短回文重複序列 (CRISPR)-Cas9 是一項獨特的技術，它允許遺傳學家和醫學研究人員透過移除、添加或改變部分去氧核糖核酸(DNA) 序列來編輯基因組。 CRISPR-Cas9 系統由兩種主要分子組成，它們將突變引入 DNA。一種是名為 Cas9 的酵素。它就像一把“分子剪刀”，在基因組的特定位置切斷 DNA 的兩條鏈。第二種成分稱為嚮導 RNA (gRNA)。它由一段預先設計的小 RNA 序列（約 20 個鹼基長）組成，該序列位於一段較長的 RNA 支架內。此支架與 DNA 結合，預先設計的序列將 Cas9 「引導」至基因組的正確位置。這使得 Cas9 酶能夠在基因組的正確位置進行切割。

市場動態

主要參與企業正在開發一系列利用 CRISPR 和 CAS 基因治療遺傳疾病的治療方法。例如，2016 年，總部位於美國的 Addgene 公司開發了 KamiCas9，這是 CRISPR-Cas9 的一個版本，其中包含「自我惰性」的 KamiCas9 系統，用於編輯中樞神經系統 (CNS) 疾病基因，以治療亨廷頓氏症。

CRISPR技術廣泛應用於開發糖尿病、癌症等疾病的治療方法。因此，預計此類疾病的日益普及將在預測期內推動市場成長。根據國際糖尿病聯盟的數據，2019年全球約有4.63億成年人（20-79歲）患有糖尿病，到2045年，這一數字將增加至7億。此外，65歲以上族群中，五分之一患有糖尿病。

此外，根據世界衛生組織（WHO）的數據，截至2018年2月，癌症已成為全球第二大死因，全球新患者約1,810萬例，死亡人數約960萬例。根據該數據統計，約70%的癌症死亡發生在中低收入國家，全球約六分之一的死亡是由癌症引起的。

研究的主要特點

本報告對全球 CRISPR 和 CAS 基因市場進行了詳細分析，並以 2024 年為基準年，對 2025 年至 2032 年期間的市場規模進行了預測。
它揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要企業採用的競爭策略的重要見解。
該報告根據公司概況、財務表現、產品系列、地理位置、分銷策略、關鍵發展和策略以及未來計劃等參數，概述了全球 CRISPR 和 CAS 基因市場的主要企業。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術改進、市場擴張和行銷策略做出明智的決策。
全球 CRISPR 和 CAS 基因市場報告迎合了該行業的各個相關人員，例如投資者、供應商、製造商、經銷商、新進業者和金融分析師。
相關人員可以透過 CRISPR 和 CAS 基因市場分析中使用的各種策略矩陣更輕鬆地做出決策。

介紹
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 東南亞國協
- 澳洲
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 北非
- 中部非洲
- 南非

第8章競爭態勢

公司簡介
- Thermo Fisher Scientific Inc.
- Merck KGaA（Sigma-Aldrich）
- OriGene Technologies, Inc.
- New England Biolabs
- Cellecta, Inc.
- Agilent Technologies
- Applied StemCell, Inc.
- Synthego
- Genscript
- Mirus Bio LLC
- Integrated DNA Technologies, Inc.
- Mammoth Biosciences, Inc.

第9章章節

參考
調查方法

簡介目錄

Product Code: CMI2598

Crispr And Cas Gene Market is estimated to be valued at USD 2.32 Bn in 2025 and is expected to reach USD 9.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2.32 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	22.80%	2032 Value Projection:	USD 9.77 Bn

Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 is a unique technology that enables the geneticists and medical researchers to edit parts of the genome by removing, adding or altering sections of the deoxyribonucleic acids (DNA) sequence. The CRISPR-Cas9 system consists of two key molecules that introduce a mutation into the DNA. The first component is an enzyme, which is called as Cas9. This acts as a pair of 'molecular scissors' that can cut the two strands of DNA at a specific location in the genome so that bits of DNA can then be added or removed. The second component is called guide RNA (gRNA). This consists of a small piece of pre-designed RNA sequence (about 20 bases long) located within a longer RNA scaffold. The scaffold part binds to DNA and the pre-designed sequence 'guides' Cas9 to the right part of the genome. This makes sure that the Cas9 enzyme cuts at the right point in the genome.

Market Dynamics

Key players are developing various treatment options, such as CRISPR and CAS genes, for genetic diseases. For instance, in 2016, the U.S.-based company, Addgene, developed the KamiCas9, a version of CRISPR-Cas9 that includes a 'self-inactivating' KamiCas9 system for the editing of central nervous system (CNS) disease genes for the treatment of Huntington's disease.

CRISPR technology is widely used to develop therapeutics for diseases such as diabetes, cancer, etc. Hence, the increasing prevalence of such diseases is expected to drive the market growth over the forecast period. According to The International Diabetes Federation, in 2019, approximately 463 million adults (20-79 years of age) were living with diabetes; by 2045, this will increase to 700 million worldwide. Moreover, one in five of the people who are above 65 years old have diabetes.

Furthermore, according to data findings by the World Health Organization (WHO), in February 2018, cancer was the second-leading cause of death globally, and around 18.1 million new cases and 9.6 million deaths were registered due to cancer. According to the same source, around 70% of deaths from cancer occurred in low and middle income countries, and around one in six deaths across the globe were caused by cancer.

Key features of the study:

This report provides an in-depth analysis of global CRISPR and CAS gene market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global CRISPR and CAS gene market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global CRISPR and CAS gene market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the CRISPR and CAS gene market

Detailed Segmentation:

Global CRISPR and CAS Gene Market, By Product Type:
- Vector-based CAS
- DNA-free CAS
- Others
Global CRISPR and CAS Gene Market, By Application:
- Genome Engineering
- Disease Models
- Functional Genomics
- Knockdown/Activation
- Others
Global CRISPR and CAS Gene Market, By End User:
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
Global CRISPR and CAS Gene Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA (Sigma-Aldrich)
- OriGene Technologies, Inc.
- New England Biolabs
- Cellecta, Inc.
- Agilent Technologies, Inc.
- Applied StemCell, Inc.
- Synthego
- Genscript
- Mirus Bio LLC
- Integrated DNA Technologies, Inc.
- Mammoth Biosciences, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trends
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER's Analysis

4. Global Crispr And Cas Gene Market, By Product Type, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Vector-based Cas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
DNA-free Cas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

5. Global Crispr And Cas Gene Market, By Application, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Genome Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Disease Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Functional Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Knockdown/Activation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

6. Global Crispr And Cas Gene Market, By End User, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Academic & Government Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Crispr And Cas Gene Market, By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country/Region, 2020 -2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck KGaA (Sigma-Aldrich)
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- OriGene Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- New England Biolabs
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cellecta, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Agilent Technologies
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Applied StemCell, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Synthego
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Genscript
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mirus Bio LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Integrated DNA Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mammoth Biosciences, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
  - Analysts' Views